{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:10:18Z","timestamp":1791274218923,"version":"4.1.0"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/wno.0b013e31814b273d","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:31:20Z","timestamp":1236191480000},"page":"238-240","source":"Crossref","is-referenced-by-count":69,"title":["Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy With Intravitreal Bevacizumab"],"prefix":"10.1097","volume":"27","author":[{"given":"Jeffrey L","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210126","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability.","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"key":"R2-13-20210126","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.1995.03520320035038","article-title":"Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R3-13-20210126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00417-006-0494-0","article-title":"Optic disc edema in non-arteritic anterior ischemic optic neuropathy.","volume":"245","author":"Hayreh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-13-20210126","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1210\/en.2006-0657","article-title":"Low-dosedopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability withoutaltering VEGF receptor 2-dependent luteal angiogenesis in a ratovarian hyperstimulation model.","volume":"147","author":"Gomez","year":"2006","journal-title":"Endocrinology"},{"key":"R5-13-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-6420(99)00133-5","article-title":"Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy.","volume":"107","author":"Johnson","year":"2000","journal-title":"Ophthalmology"},{"key":"R6-13-20210126","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1172\/JCI8218","article-title":"VEGF antagonismreduces edema formation and tissue damage after ischemia\/reperfusion injury in the mouse brain.","volume":"104","author":"van Bruggen","year":"1999","journal-title":"J Clin Invest"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNO.0b013e31814b273d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:38:26Z","timestamp":1786037906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041327-200709000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e31814b273d","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}